Quality survey Health benefits Safety Reading labels Ask the supplier Standards & regulations


Testing news
Ask the expert
Contact us
Privacy policy

Research news

Scientists and Physicians Discuss Latest Discoveries for Stopping Cancer before It Starts
Philadelphia PA, 31 October 2003

More than 650 scientists and clinicians from around the world gathered in Phoenix, Arizona on October 26-30, 2003 at the second annual American Association for Cancer Research (AACR) International Conference on Frontiers in Cancer Prevention Research.

Novel findings reported at the conference include:

  • A low-carbohydrate diet, rather than a low-fat diet, may halt the progression of prostate cancer. Conversely, vitamin A and related compounds present in dairy products, beef fat and fish oil, slow the growth of prostate tumors.

  • Eating fruits and vegetables reduces breast cancer risk but may not impede colorectal cancer, while ginger potentially can.

  • Drinking green tea helps the body retain an enzyme that inhibits the formation of certain lesions and tumors.

  • The antioxidants in grapes and wine decrease the odds of developing skin cancer from exposure to ultraviolet light; so do some non-steroidal anti-inflammatory drugs.

  • Changes in the nucleus of some cells can serve as predictors of cancer susceptibility.

"Over the past five years there have been significant advances in our understanding of the signaling pathways responsible for the development of both pre-invasive and invasive cancers," said Raymond N. DuBois, PhD, MD, meeting chairperson and Professor of Medicine and Cell Biology and Director, Division of Gastroenterology, Vanderbilt University Medical Center, Nashville TN.

"This meeting will provide a venue for discussion of our current strategies for cancer prevention and for a critical evaluation of exciting new opportunities to reduce the high burden of cancer on our society by using better diagnostics, predictive markers and personalized medicine," he added.

A sea change in the war on cancer is quietly under way in the laboratories of medical centers, research hospitals, universities, government health agencies and pharmaceutical companies globally. The burgeoning field of cancer prevention research—the quest to identify drugs and other substances that will ward off the onset of cancer, hinder its progress, reverse its course or diminish the chances of its recurrence—is augmenting the search for a cure.

"AACR launched the annual cancer prevention meetings last year, to facilitate the exchange of research results from laboratories and clinical trials, foster translational research, and strengthen the vitally important partnership among basic scientists, clinical oncologists, physician-scientists, behavioral scientists, and epidemiologists from academia, government, and industry, as well as cancer survivor groups," said Karen S. H. Antman, MD, AACR president and Wu Professor of Medicine and Professor of Pharmacology, Division of Oncology, Department of Medicine, Columbia University, New York.

"This second annual, multidisciplinary conference will link the biology of the cancer process with its clinical prevention and reversal in pre-invasive stages," she added.

Founded in 1907, the American Association for Cancer Research is a professional society of more than 21,000 laboratory, translational, and clinical scientists engaged in cancer research in the United States and in more than 60 other countries. AACR's mission is to accelerate the prevention and cure of cancer through research, education, communication, and advocacy. Its principal activities include the publication of five major peer-reviewed scientific journals: Cancer Research; Clinical Cancer Research; Molecular Cancer Therapeutics; Molecular Cancer Research; and Cancer Epidemiology, Biomarkers & Prevention. AACR's annual meetings—next year in Orlando FL, March 27-31—attract more than 15,000 participants who share new and significant discoveries in the cancer field. Specialty meetings like this one, held throughout the year, focus on the latest developments in all areas of cancer research.


American Association for Cancer Research.end-of-story


Health benefits Safety Reading labels Ask the supplier Standards & regulations Contact us

(c) Copyright 1999-2003 Dietary Supplement Quality Initiative. For permission to reprint, please contact our editor.